Blood tests can detect cancer — but not in the way most people expect. A single blood test cannot definitively diagnose cancer on its own. However, specific blood tests identify markers that strongly indicate cancer’s presence, track its progression, and monitor treatment response.
Understanding which blood tests detect cancer markers, what their results mean, and what their limitations are helps you make informed decisions about your health. Moreover, knowing when to request these tests could save your life — because cancer caught early is almost always more treatable.
This guide covers every important cancer-related blood test, what each one detects, and when to get tested at Prakash Pathology, Varanasi.
How Blood Tests Detect Cancer — The Science Behind It
Cancer cells behave differently from normal cells. They divide uncontrollably, consume resources aggressively, and release specific proteins, enzymes, and genetic fragments into the bloodstream. Moreover, cancer disrupts normal organ function — producing measurable changes in routine blood parameters.
Blood tests detect cancer through two primary mechanisms. First, tumour marker tests identify specific proteins that cancer cells produce in elevated quantities. Second, routine blood tests — like the CBC and LFT — detect abnormal patterns that indicate cancer’s indirect effects on the body.
Why No Single Test Confirms Cancer Alone
A positive tumour marker does not automatically confirm cancer. Moreover, some non-cancerous conditions also elevate tumour markers. Consequently, doctors always combine blood test results with imaging, biopsy, and clinical examination before reaching a cancer diagnosis.
Furthermore, a normal tumour marker result does not completely rule out cancer — because not all cancers elevate every marker consistently. This is why understanding both the power and the limitations of these tests is essential.
Blood Tests That Help Detect Cancer
1. Complete Blood Count (CBC) — The First Indicator
The CBC is the most commonly ordered blood test in medicine. It measures red blood cells, white blood cells, and platelets. Moreover, several patterns in a CBC reading strongly suggest certain cancers — even before any specific tumour marker test is ordered.
What the CBC reveals about cancer:
- Very high WBC count — particularly above 30,000 cells per µL with abnormal cell types — is a primary indicator of leukaemia
- Very low platelet count combined with abnormal WBC — suggests bone marrow involvement by cancer
- Persistent anaemia without an obvious nutritional cause — can indicate bone marrow suppression from cancer or chronic blood loss from a tumour
- Abnormal cell types on the differential count — blast cells or immature cells suggest leukaemia or lymphoma
When CBC Results Prompt Further Testing
A single abnormal CBC does not diagnose cancer. However, persistently abnormal results — particularly a rising WBC count without infection, or a falling platelet count without obvious cause — always prompt a peripheral blood smear and specialist referral. Furthermore, catching these patterns early through routine annual CBC testing is one of the most accessible forms of cancer screening available.
2. Tumour Markers — Specific Cancer Indicators
Tumour markers are proteins, hormones, or other substances that cancer cells produce in elevated quantities. Blood tests detect cancer through tumour markers most specifically — making these the most targeted cancer screening tools available.
| Tumour Marker | Cancer It Indicates | Normal Range |
|---|---|---|
| PSA (Prostate Specific Antigen) | Prostate cancer | Below 4 ng/mL |
| CA 125 | Ovarian cancer | Below 35 U/mL |
| CA 19-9 | Pancreatic, bile duct cancer | Below 37 U/mL |
| CA 15-3 | Breast cancer | Below 30 U/mL |
| CEA (Carcinoembryonic Antigen) | Colorectal, lung, breast cancer | Below 2.5 ng/mL (non-smokers) |
| AFP (Alpha-Fetoprotein) | Liver cancer, testicular cancer | Below 10 ng/mL |
| Beta-HCG | Testicular cancer, choriocarcinoma | Below 5 mIU/mL |
| LDH (Lactate Dehydrogenase) | Lymphoma, leukaemia, testicular cancer | 140 – 280 U/L |
How to Interpret Tumour Marker Results
Elevated tumour markers are significant — but not conclusive alone. Moreover, the degree of elevation matters considerably. A mildly elevated PSA may indicate prostate enlargement rather than cancer. However, a dramatically elevated AFP strongly suggests liver cancer and warrants urgent investigation.
Furthermore, tumour markers are most valuable when tracked over time. A rising marker trend is often more informative than a single high reading. Consequently, doctors order repeat tests at intervals to assess whether levels are stable, falling, or rising progressively.
3. Liver Function Test (LFT) — Detecting Liver Cancer Signals
The liver is one of the most common sites of both primary cancer and metastatic spread from other cancers. An LFT measures several liver enzymes and proteins. Moreover, specific abnormal patterns in LFT results raise strong suspicion of liver involvement.
LFT patterns that suggest cancer:
- Significantly elevated ALP (Alkaline Phosphatase) — suggests liver metastases or bile duct obstruction from a tumour
- Elevated GGT alongside high ALP — strongly suggests hepatocellular carcinoma or metastatic liver disease
- Rising bilirubin alongside declining albumin — indicates failing liver synthetic function, often from advanced liver disease or cancer
Additionally, doctors always order an AFP test alongside an LFT when liver cancer is suspected — because elevated AFP combined with abnormal LFT findings significantly strengthens the diagnostic picture.
4. PSA Test — Prostate Cancer Screening
The PSA test is the most widely used cancer screening blood test for men above 50. Prostate cells — both normal and cancerous — produce PSA. However, prostate cancer cells produce it in far greater quantities.
Understanding PSA results:
- Below 4 ng/mL — generally considered normal
- 4 to 10 ng/mL — borderline. Further evaluation needed — prostate cancer present in approximately 25 percent of cases at this level
- Above 10 ng/mL — high suspicion for prostate cancer. Biopsy strongly recommended
- Rapidly rising PSA over time — even within the normal range — is often more significant than a single elevated reading
Moreover, the PSA test is not perfect. Some prostate cancers do not elevate PSA significantly. Consequently, doctors combine PSA results with digital rectal examination and imaging before confirming any diagnosis.
5. CA 125 — Ovarian Cancer Screening
CA 125 is a protein produced by ovarian cancer cells. It is the primary blood marker for ovarian cancer monitoring. Moreover, it is particularly useful for tracking treatment response in women already diagnosed with ovarian cancer.
Important limitations of CA 125:
CA 125 is not a perfect screening tool for women without symptoms. Several non-cancerous conditions — including endometriosis, fibroids, pelvic inflammatory disease, and even pregnancy — elevate CA 125 levels. Consequently, an elevated CA 125 in a woman with pelvic pain or bloating prompts further imaging — it does not confirm cancer alone.
However, a significantly elevated CA 125 — particularly above 200 U/mL — in a postmenopausal woman with pelvic symptoms warrants urgent specialist evaluation without delay.
6. CEA — Colorectal Cancer Monitoring
CEA — Carcinoembryonic Antigen — is a protein elevated in several cancers, particularly colorectal cancer. Moreover, CEA is most valuable for monitoring colorectal cancer after treatment — tracking whether cancer has recurred following surgery or chemotherapy.
What elevated CEA suggests:
A CEA above 5 ng/mL in a non-smoker with digestive symptoms — particularly changes in bowel habits, blood in stool, or unexplained weight loss — warrants a colonoscopy without delay. Furthermore, a rising CEA trend in a patient previously treated for colorectal cancer almost always indicates recurrence — prompting immediate imaging and specialist review.
7. AFP — Liver and Testicular Cancer
AFP — Alpha-Fetoprotein — is normally produced in large quantities during foetal development. In adults, very low AFP levels are normal. However, significantly elevated AFP in an adult strongly suggests liver cancer or testicular cancer.
AFP levels and their significance:
- 10 to 100 ng/mL — mildly elevated. Requires further investigation with liver imaging
- 100 to 400 ng/mL — moderately elevated. Strong suspicion for hepatocellular carcinoma
- Above 400 ng/mL — highly suggestive of liver cancer. Urgent specialist referral required
Moreover, AFP is particularly important in India — where hepatitis B and C infections are common, and both significantly increase the risk of developing liver cancer. Consequently, regular AFP monitoring alongside abdominal ultrasound is strongly recommended for patients with chronic hepatitis or liver cirrhosis.
8. LDH — Lymphoma and Leukaemia
LDH — Lactate Dehydrogenase — is an enzyme found in virtually every cell in the body. When cells are damaged or destroyed rapidly — as happens in aggressive cancers — LDH levels rise sharply. Moreover, significantly elevated LDH is a consistent finding in lymphoma, leukaemia, and testicular cancer.
What elevated LDH indicates:
LDH is not a specific cancer marker — many conditions elevate it. However, a dramatically elevated LDH alongside other abnormal findings — particularly an abnormal CBC, swollen lymph nodes, or unexplained weight loss — significantly raises suspicion for haematological malignancy. Consequently, doctors use LDH alongside other markers to assess cancer severity and prognosis rather than as a standalone screening tool.
What Blood Tests Cannot Do
Understanding the limitations of cancer blood tests is as important as understanding their capabilities. Blood tests detect cancer signals — but they cannot:
- Definitively diagnose cancer alone — a biopsy is always required for a confirmed diagnosis
- Pinpoint the exact location of a tumour — imaging (CT, MRI, PET scan) is needed for this
- Detect every cancer type — many cancers produce no measurable blood marker
- Rule out cancer completely — a normal result reduces suspicion but does not guarantee cancer’s absence
Furthermore, false positive results — elevated markers without cancer — are relatively common. This is why doctors always interpret blood test results in the full clinical context — not in isolation.
Who Should Get Cancer Blood Tests Done?
Routine cancer marker screening is not recommended for everyone. However, certain individuals benefit significantly from regular testing:
- Men above 50 — PSA test for prostate cancer screening annually
- Women above 40 with family history of ovarian cancer — CA 125 alongside pelvic ultrasound
- Anyone with chronic hepatitis B or C or liver cirrhosis — AFP and LFT every 6 months
- Colorectal cancer survivors — CEA monitoring every 3 to 6 months post-treatment
- Anyone with persistent unexplained symptoms — unexplained weight loss, fatigue, blood in stool, or a palpable lump — warrants a targeted blood panel immediately
Additionally, anyone with a strong family history of any cancer should discuss appropriate screening schedules with their doctor — because genetic risk significantly increases the value of early and regular blood test monitoring.
Frequently Asked Questions
Can blood tests detect cancer early? Yes — certain blood tests detect cancer markers at early stages, particularly for liver cancer (AFP), prostate cancer (PSA), and ovarian cancer (CA 125). However, blood tests work best as part of a broader screening programme — combined with imaging and clinical examination — rather than as standalone early detection tools.
Which blood test is used to detect cancer in India? The most commonly used cancer-related blood tests in India include CBC (for leukaemia and lymphoma), PSA (prostate cancer), CA 125 (ovarian cancer), CEA (colorectal cancer), AFP (liver cancer), and CA 19-9 (pancreatic cancer). All of these are available at Prakash Pathology & Radiology, Varanasi.
Can a normal blood test rule out cancer completely? No — a normal blood test significantly reduces suspicion but cannot rule out cancer entirely. Some cancers produce no measurable blood markers. Furthermore, tumour marker levels can be normal in early-stage cancer. Consequently, persistent symptoms always warrant further investigation regardless of blood test results.
How accurate are tumour marker blood tests? Tumour marker tests vary in accuracy depending on the cancer type and stage. Moreover, non-cancerous conditions can elevate many markers — producing false positive results. Doctors always interpret tumour markers alongside imaging, symptoms, and clinical examination rather than relying on blood results alone.
Where can I get cancer blood tests done in Varanasi? All major cancer screening blood tests — including CBC, PSA, CA 125, CEA, AFP, CA 19-9, CA 15-3, LDH, and LFT — are available at Prakash Pathology & Radiology, Varanasi. Results are processed on modern diagnostic equipment with fast turnaround. Book your appointment online at prakashpathradio.com.
Get Cancer Screening Blood Tests at Prakash Pathology, Varanasi
Early detection changes outcomes. Blood tests that detect cancer markers give you and your doctor a critical head start — particularly for cancers where early-stage treatment is dramatically more effective than late-stage intervention.
At Prakash Pathology & Radiology, Varanasi, all major cancer screening blood tests are available under one roof. Our pathology services use modern, calibrated diagnostic equipment — delivering accurate, reliable results with fast turnaround. You can view all available tests and book your appointment online in just a few minutes.
Contact us today if you have questions about which tests are right for your specific symptoms or risk profile. Our team is here to help you get clear answers quickly.
According to the Indian Council of Medical Research (ICMR), early detection through targeted screening — including blood-based tumour marker testing — remains one of the most effective strategies for improving cancer survival outcomes across India.
⚠️ Medical Disclaimer: This blog is for general informational purposes only and does not constitute medical advice. Always consult a qualified doctor for interpretation of test results and personalised health guidance.